After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Acrivon Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Acrivon Therapeutics Inc is $61.85M. A total of 2.14 million shares were traded on the day, compared to an average of 1.64M shares.
In the most recent transaction, Blume-Jensen Peter bought 49,000 shares of ACRV for 1.68 per share on Jan 14 ’26. After the transaction, the President and CEO now owns 2,095,771 company shares. In a previous transaction on Jan 14 ’26, Levy Adam D. bought 8,832 shares at 1.70 per share. ACRV shares that Chief Financial Officer owns now total 20,983.
Among the insiders who bought shares, Devroe Eric acquired of 10,000 shares on Jan 13 ’26 at a per-share price of $1.72. This resulted in the Chief Operating Officer holding 75,308 shares of ACRV after the transaction. In another insider transaction, PERCEPTIVE ADVISORS LLC sold 437,881 shares at $1.41 per share on Apr 30 ’25. Company shares held by the 10% Owner now total 3,403,025.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ACRV has a high of $8.00 and a low of $1.05.
As of this writing, ACRV has an earnings estimate of -$0.46 per share for the current quarter. EPS was calculated based on a consensus of 8.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.54 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ACRV’s latest balance sheet shows that the firm has $99.60M in Cash & Short Term Investments as of fiscal 2021. There were $5.63M in debt and $2.91M in liabilities at the time. Its Book Value Per Share was $4.08, while its Total Shareholder’s Equity was -$23.81M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
